Resende Paola Cristina, Delatorre Edson, Gräf Tiago, Mir Daiana, Motta Fernando Couto, Appolinario Luciana Reis, da Paixão Anna Carolina Dias, Mendonça Ana Carolina da Fonseca, Ogrzewalska Maria, Caetano Braulia, Wallau Gabriel Luz, Docena Cássia, Dos Santos Mirleide Cordeiro, de Almeida Ferreira Jessylene, Sousa Junior Edivaldo Costa, da Silva Sandro Patroca, Fernandes Sandra Bianchini, Vianna Lucas Alves, Souza Larissa da Costa, Ferro Jean F G, Nardy Vanessa B, Santos Cliomar A, Riediger Irina, do Carmo Debur Maria, Croda Júlio, Oliveira Wanderson K, Abreu André, Bello Gonzalo, Siqueira Marilda M
Laboratory of Respiratory Viruses and Measles, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (FIOCRUZ), SARS-CoV-2 National Reference Laboratory for the Brazilian Ministry of Health (MoH) and Regional Reference Laboratory in Americas for the Pan-American Health Organization (PAHO/WHO), Rio de Janeiro, Brazil.
Departamento de Biologia, Centro de Ciencias Exatas, Naturais e da Saude, Universidade Federal do Espirito Santo, Alegre, Brazil.
Front Microbiol. 2021 Feb 17;11:615280. doi: 10.3389/fmicb.2020.615280. eCollection 2020.
A previous study demonstrates that most of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) Brazilian strains fell in three local clades that were introduced from Europe around late February 2020. Here we investigated in more detail the origin of the major and most widely disseminated SARS-CoV-2 Brazilian lineage B.1.1.33. We recovered 190 whole viral genomes collected from 13 Brazilian states from February 29 to April 31, 2020 and combined them with other B.1.1 genomes collected globally. Our genomic survey confirms that lineage B.1.1.33 is responsible for a variable fraction of the community viral transmissions in Brazilian states, ranging from 2% of all SARS-CoV-2 genomes from Pernambuco to 80% of those from Rio de Janeiro. We detected a moderate prevalence (5-18%) of lineage B.1.1.33 in some South American countries and a very low prevalence (<1%) in North America, Europe, and Oceania. Our study reveals that lineage B.1.1.33 evolved from an ancestral clade, here designated B.1.1.33-like, that carries one of the two B.1.1.33 synapomorphic mutations. The B.1.1.33-like lineage may have been introduced from Europe or arose in Brazil in early February 2020 and a few weeks later gave origin to the lineage B.1.1.33. These SARS-CoV-2 lineages probably circulated during February 2020 and reached all Brazilian regions and multiple countries around the world by mid-March, before the implementation of air travel restrictions in Brazil. Our phylodynamic analysis also indicates that public health interventions were partially effective to control the expansion of lineage B.1.1.33 in Rio de Janeiro because its median effective reproductive number ( ) was drastically reduced by about 66% during March 2020, but failed to bring it to below one. Continuous genomic surveillance of lineage B.1.1.33 might provide valuable information about epidemic dynamics and the effectiveness of public health interventions in some Brazilian states.
此前的一项研究表明,大多数严重急性呼吸综合征冠状病毒2(SARS-CoV-2)巴西毒株属于三个本地进化枝,这些进化枝于2020年2月下旬从欧洲传入。在此,我们更详细地研究了主要且传播最广泛的SARS-CoV-2巴西谱系B.1.1.33的起源。我们获取了2020年2月29日至4月31日期间从巴西13个州收集的190个完整病毒基因组,并将它们与全球收集的其他B.1.1基因组相结合。我们的基因组调查证实,谱系B.1.1.33在巴西各州的社区病毒传播中占比各不相同,从伯南布哥州所有SARS-CoV-2基因组的2%到里约热内卢州的80%。我们在一些南美国家检测到谱系B.1.1.33的中度流行率(5 - 18%),而在北美、欧洲和大洋洲的流行率非常低(<1%)。我们的研究表明,谱系B.1.1.33由一个祖先进化枝进化而来,在此命名为类B.1.1.33,该祖先进化枝携带B.1.1.33两个共有衍征突变之一。类B.1.1.33谱系可能于2020年2月初从欧洲传入或在巴西出现,几周后产生了谱系B.1.1.33。这些SARS-CoV-2谱系可能在2020年2月期间传播,并在3月中旬巴西实施航空旅行限制之前传播到巴西所有地区及世界多个国家。我们的系统动力学分析还表明,公共卫生干预措施在控制里约热内卢谱系B.1.1.33的扩张方面部分有效,因为其有效再生数中位数( )在2020年3月期间大幅降低了约66%,但未能使其降至1以下。对谱系B.1.1.33进行持续的基因组监测可能会提供有关巴西一些州疫情动态和公共卫生干预措施有效性的有价值信息。